Are Vancomycin Trough Concentrations Adequate for Optimal Dosing?

Vancomycin AUC/MIC Ratio and 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia

(2013) Natasha E. Holmes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A Stewardship Program’s Retrospective Evaluation of Vancomycin AUC24/MIC and Time to Microbiological Clearance in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia and Osteomyelitis

(2013) Kristen M. Gawronski et al.   CLINICAL THERAPEUTICS

Two general methods for population pharmacokinetic modeling: non-parametric adaptive grid and non-parametric Bayesian

(2013) Tatiana Tatarinova et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Desired Vancomycin Trough Serum Concentration for Treating Invasive Methicillin-resistant Staphylococcal Infections

(2013) Adam Frymoyer et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Improved Vancomycin Dosing in Children Using Area Under the Curve Exposure

(2013) Jennifer Le et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Comparison of Four Renal Function Estimation Equations for Pharmacokinetic Modeling of Gentamicin in Geriatric Patients

(2012) Nicolas Charhon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Is Peak Concentration Needed in Therapeutic Drug Monitoring of Vancomycin? A Pharmacokinetic-Pharmacodynamic Analysis in Patients with Methicillin-ResistantStaphylococcus aureusPneumonia

(2012) Yosuke Suzuki et al.   CHEMOTHERAPY

Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study

(2012) R. G. Wunderink et al.   CLINICAL INFECTIOUS DISEASES

Incidence of Nephrotoxicity and Association With Vancomycin Use in Intensive Care Unit Patients With Pneumonia: Retrospective Analysis of the IMPACT-HAP Database

(2012) Ennie L. Cano et al.   CLINICAL THERAPEUTICS

Vancomycin therapeutics and monitoring: a contemporary approach

(2012) M. L. Avent et al.   INTERNAL MEDICINE JOURNAL

Effects of Targeting Higher Vancomycin Trough Levels on Clinical Outcomes and Costs in a Matched Patient Cohort

(2012) Ravina Kullar et al.   PHARMACOTHERAPY

Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R

(2012) Michael N. Neely et al.   THERAPEUTIC DRUG MONITORING

Vancomycin Dosing: Assessment of Time to Therapeutic Concentration and Predictive Accuracy of Pharmacokinetic Modeling Software

(2011) Maya O Nunn et al.   ANNALS OF PHARMACOTHERAPY

Penetration of Vancomycin into Epithelial Lining Fluid in Healthy Volunteers

(2011) Thomas P. Lodise et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Vancomycin AUC24/MIC Ratio in Patients with Complicated Bacteremia and Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus and Its Association with Attributable Mortality during Hospitalization

(2011) Jack Brown et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets

(2011) R. Kullar et al.   CLINICAL INFECTIOUS DISEASES

Vancomycin

(2011) Amélie Marsot et al.   CLINICAL PHARMACOKINETICS

Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis

(2011) M. A. Cataldo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Increasing Vancomycin Serum Trough Concentrations and Incidence of Nephrotoxicity

(2010) Lindsey Pritchard et al.   AMERICAN JOURNAL OF MEDICINE

Practical, Individualized Dosing: 21st Century Therapeutics and the Clinical Pharmacometrician

(2010) Michael Neely et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Relationship between Initial Vancomycin Concentration‐Time Profile and Nephrotoxicity among Hospitalized Patients

(2009) Thomas P. Lodise et al.   CLINICAL INFECTIOUS DISEASES

Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

(2008) M. Rybak et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Practical Therapeutic Drug Management in HIV-Infected Patients: Use of Population Pharmacokinetic Models Supplemented by Individualized Bayesian Dose Optimization

(2008) Michael Neely et al.   JOURNAL OF CLINICAL PHARMACOLOGY